| __timestamp | ImmunityBio, Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 1595000 | 855506000 |
| Thursday, January 1, 2015 | 11434000 | 996170000 |
| Friday, January 1, 2016 | 26546000 | 1047690000 |
| Sunday, January 1, 2017 | 39778000 | 1324625000 |
| Monday, January 1, 2018 | 53418000 | 1416476000 |
| Tuesday, January 1, 2019 | 111997000 | 1754540000 |
| Wednesday, January 1, 2020 | 139507000 | 1829537000 |
| Friday, January 1, 2021 | 195958000 | 3051100000 |
| Saturday, January 1, 2022 | 248149000 | 2540300000 |
| Sunday, January 1, 2023 | 232366000 | 3162900000 |
| Monday, January 1, 2024 | 3630300000 |
Unleashing insights
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Vertex Pharmaceuticals Incorporated and ImmunityBio, Inc. have demonstrated contrasting trajectories in their R&D investments.
Since 2014, Vertex Pharmaceuticals has consistently increased its R&D expenses, peaking in 2023 with a staggering $3.16 billion. This represents a nearly fourfold increase from their 2014 spending, underscoring their dedication to pioneering treatments.
ImmunityBio, while starting from a modest base, has shown remarkable growth in R&D spending, with a 145-fold increase from 2014 to 2023. Their 2023 expenditure reached $232 million, highlighting their aggressive push into the biotech arena.
These trends reflect the dynamic nature of the biotech industry, where strategic R&D investments can drive future breakthroughs.
Research and Development Investment: Vertex Pharmaceuticals Incorporated vs Regeneron Pharmaceuticals, Inc.
R&D Insights: How Vertex Pharmaceuticals Incorporated and Viatris Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Vertex Pharmaceuticals Incorporated and Exelixis, Inc.
Research and Development Expenses Breakdown: Vertex Pharmaceuticals Incorporated vs Viking Therapeutics, Inc.
Vertex Pharmaceuticals Incorporated vs Catalyst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Vertex Pharmaceuticals Incorporated vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Vertex Pharmaceuticals Incorporated and Novavax, Inc.
R&D Insights: How Biogen Inc. and ImmunityBio, Inc. Allocate Funds
Viatris Inc. or ImmunityBio, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Blueprint Medicines Corporation and ImmunityBio, Inc.
ImmunityBio, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for ImmunityBio, Inc. and Mesoblast Limited